1 / 11

Chemical & Biological Defense Program Science & Technology

Chemical & Biological Defense Program Science & Technology. COL Ben Hagar Deputy, Joint Science & Technology Office for CB Defense Defense Threat Reduction Agency. Overview. Continued strong Department and Congressional support for CBDP S&T

sheng
Download Presentation

Chemical & Biological Defense Program Science & Technology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chemical & Biological Defense Program Science & Technology COL Ben Hagar Deputy, Joint Science & Technology Office for CB Defense Defense Threat Reduction Agency JSTO

  2. Overview • Continued strong Department and Congressional support for CBDP S&T • Strengthened ability to transition from DARPA programs • DTRA re-aligning its R&D efforts • STRATCOM Combating WMD role JSTO

  3. Answer Science Questions Transition Technologies Maintain Robust Tech Base Preserving warfighter effectiveness through medical countermeasures Diagnostics Pretreatments/ Prophylaxes Emerging Threats/ Special Programs Therapeutics JSTO

  4. Detection Answer Science Questions Transition Technologies Protection Maintain Robust Tech Base Decontamination Supporting S&T Modeling and Simulation Preserving warfighter effectiveness with advanced equipment and materials JSTO

  5. Principle “Plain Language” Thrusts • Earliest Warning • Detection • Medical Surveillance • Information Dissemination • Broad Spectrum Medical Countermeasures • Pretreatment • Therapeutics • “How Clean is Safe?” • Decontamination • Low-Level Toxicology • Environmental Fate of Agent JSTO

  6. Medical CB S&T Strategy • Place greater emphasis on developing medical countermeasures effective against a broader range of pathogens to mitigate novel agent effects • Accelerate development cycle (rapid vaccine and drug development) • Exploit cutting edge technologies to improve medical countermeasures against established high-priority CB agents and against emerging CB agents and effects • Leverage existing capability found in other federal agencies, industry, and international partners • Sustain long-term investment in developing candidates for capability gaps • Ensure knowledge base to support future technology development JSTO

  7. Physical S&T program strategy Balance between requirements pull: • Align with the JRO to address capability needs • Align with JPEO programs to address technology gaps • Answer critical science questions that support policy, doctrine and requirements decisions … and technology push: • Centralize investment in basic research (6.1) • Identify and exploit technology opportunities • Identify and respond to new and emerging threats • Transition new and innovative technologies with JPEO • Maintain a robust technology base: knowledge, research capabilities, and test and evaluation methodologies JSTO

  8. How we have changed the Physical S&T business strategy … Find and Fund the Best Performers: • Maintain an active outreach to a broad base of potential performers in government, academia, and industry • Emphasize teaming and comprehensive approaches • Allow the best ideas to emerge through competition • Select the best science and most innovative ideas: no favorites, no quotas Exploit Cutting Edge Technologies: • Find and fund new cross-cutting technologies • Leverage new ideas from other sources Sustain Long-Term Investment: • Fund promising technologies from concept through transition JSTO

  9. …and developed an overarching science strategy … Build a Fundamental Understanding of CB Agents: • Physical and chemical properties • Fundamental interactions with other materials and environment • Pathological and toxicological properties • Exploitable signatures Leverage Advancements in Strategic Research: Develop Revolutionary Solutions: • Integrated system for complete knowledge of the CB environment • Unencumbering full protection • Rapid inactivation of CB hazards • Information dominance • Nanoscience • Bioengineering sciences • Multifunctional materials • Human performance science JSTO

  10. FY05($M) FY06($M) Increase CB.1 6.3 15.7 150% CB.2 62.1 104.3 68% CB.3 39.9 60.8 53% Total 108.2 180.8 67% Detection 33.9 43.9 30% MSB 9.1 38.4 324% Protection 9.6 19.7 106% Decon 5.2 8.9 71% TAS 31.0 32.8 6% FY06 Core Funding Increases JSTO

  11. Scientific Challenges • Develop a fundamental understanding of properties and mechanisms underlying EM detection of CB agents in order to better identify and predict unique and distinguishable signatures • Formulate optimal filters for fusion of disparate sensor information in non-linear dynamic networks • Discover new materials that are sorbent and/or stably reactive which provide order-of-magnitude CB agent removal rates and capacity over current activated carbon technologies • Develop a fundamental understanding of CB agent and decontaminant transport in solid substrates to predict agent fate, removal efficacy (or neutralization), and material effects JSTO

More Related